Andros Pharmaceuticals Co (ROCO:6917) FCF Yield % : -5.03 (As of Jun. 05, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Andros Pharmaceuticals Co FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Andros Pharmaceuticals Co's Trailing 12-Month Free Cash Flow is NT$-47.22 Mil, and Market Cap is NT$937.97 Mil. Therefore, Andros Pharmaceuticals Co's FCF Yield % for today is -5.03%.

The historical rank and industry rank for Andros Pharmaceuticals Co's FCF Yield % or its related term are showing as below:

ROCO:6917' s FCF Yield % Range Over the Past 10 Years
Min: -6.47 Med: -3.97 Max: -2.82
Current: -5.03

During the past 5 years, the highest FCF Yield % of Andros Pharmaceuticals Co was -2.82%. The lowest was -6.47%. And the median was -3.97%.

ROCO:6917's FCF Yield % is ranked better than
70.44% of 1553 companies
in the Biotechnology industry
Industry Median: -14.22 vs ROCO:6917: -5.03

Andros Pharmaceuticals Co's FCF Margin % for the quarter that ended in Dec. 2023 was -8,597.67%.

Andros Pharmaceuticals Co FCF Yield % Historical Data

The historical data trend for Andros Pharmaceuticals Co's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Andros Pharmaceuticals Co FCF Yield % Chart

Andros Pharmaceuticals Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

-4.23

Andros Pharmaceuticals Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial			-	-	-	-2.66	-5.28

Competitive Comparison of Andros Pharmaceuticals Co's FCF Yield %

For the Biotechnology subindustry, Andros Pharmaceuticals Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Andros Pharmaceuticals Co's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Andros Pharmaceuticals Co's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Andros Pharmaceuticals Co's FCF Yield % falls into.

Andros Pharmaceuticals Co FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Andros Pharmaceuticals Co's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-47.222	/	1117.0614
	=	-4.23%

Andros Pharmaceuticals Co's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-29.49	*	2	/	1117.0614
	=	-5.28%

Andros Pharmaceuticals Co FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Andros Pharmaceuticals Co FCF Yield % Related Terms

Thank you for viewing the detailed overview of Andros Pharmaceuticals Co's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Andros Pharmaceuticals Co (ROCO:6917) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Andros Pharmaceuticals Co Ltd (ROCO:6917) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 22, Sec. 2, Shengyi Road, 6th Floor, Building D, Biotech Building, Hsinchu Biomedical Science Park, Hsinchu County, Zhubei City, TWN, 30261

Website

http://www.androspharma.com

Andros Pharmaceuticals Co Ltd is a biopharmaceutical company engaged in developing novel drug delivery platform technologies. The firm focuses on the development of topical new dosage forms and non-viral gene delivery systems, with the current pipeline indicated for pain management, DNA repair, and gene therapy. Its product line comprises New Dosage Forms (Topical), Super Generics (Topical), High-End Cosmetic Ingredients (Topical), and Gene Delivery Systems (Injectable).

Andros Pharmaceuticals Co (ROCO:6917) Headlines

No Headlines